First Horizon Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-47
| Closed | -$10K | – | 1596 |
|
|
2018
Q3 | $10K | Hold |
47
| – | – | ﹤0.01% | 1122 |
|
|
2018
Q2 | $102K | Hold |
47
| – | – | 0.01% | 446 |
|
|
2018
Q1 | $118K | Hold |
47
| – | – | 0.01% | 365 |
|
|
2017
Q4 | $84K | Sell |
47
-46
| -49% | -$82.2K | 0.01% | 423 |
|
|
2017
Q3 | $110K | Hold |
93
| – | – | 0.01% | 377 |
|
|
2017
Q2 | $69K | Hold |
93
| – | – | 0.01% | 430 |
|
|
2017
Q1 | $64K | Sell |
93
-821
| -90% | -$565K | 0.01% | 472 |
|
|
2016
Q4 | $100K | Buy |
914
+823
| +904% | +$90K | 0.01% | 404 |
|
|
2016
Q3 | $100K | Hold |
91
| – | – | 0.01% | 399 |
|
|
2016
Q2 | $70K | Hold |
91
| – | – | 0.01% | 452 |
|
|
2016
Q1 | $64K | Hold |
91
| – | – | 0.01% | 493 |
|
|
2015
Q4 | $90K | Hold |
91
| – | – | 0.02% | 386 |
|
|
2015
Q3 | $97K | Buy |
+91
| New | +$97K | 0.02% | 403 |
|
|
2013
Q4 | – | Sell |
-24
| Closed | -$69K | – | 1456 |
|
|
2013
Q3 | $69K | Buy |
+24
| New | +$69K | 0.01% | 408 |
|